Asher Ornoy1, Victoria Finkel-Pekarsky1, Einat Peles2, Miriam Adelson2, Shaul Schreiber2,3, P Richard Ebstein4. 1. Laboratory of Teratology, Department of Medical Neurobiology, Canada Israel Institute of Medical Research, Hebrew University Hadassah Medical School, Jerusalem, Israel. 2. Adelson clinic for drug abuse treatment & Research, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 3. Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 4. Department of Psychology, National University of Singapore, Singapore, Singapore.
Abstract
BACKGROUND: Polymorphisms in genes such as DAT1, 5HTTLPR, D4DR4, and MAO-A have been linked to attention deficit hyperactivity disorder (ADHD) and susceptibility for opiate addiction. We investigated in opiate-addicted parents and their children the rate of ADHD and genetic markers that could predict susceptibility to ADHD and/or opiate addiction. METHODS: We studied 64 heroin-addicted, methadone-maintained parents, and their 94 children who had or had not been exposed prenatally to opiates. DNA extracted from mouthwash was assessed for genetic polymorphism for six polymorphic sites of four different genes. Study subjects also filled a variety of questionnaires assessing the rate of ADHD in the parents and children and the children's intelligence quotient. RESULTS: Children of opiate-dependent mothers had a higher rate of ADHD compared to those of the opiate-dependent fathers. Opiate-dependent parents have a high risk of being carriers of most risk alleles examined except DRD4EX3 (allele 7). There was no difference whether the addicted parents had or did not have ADHD. CONCLUSIONS: Serotonergic and dopaminergic risk alleles seem to be mainly related to opiate dependence with no effect on the occurrence of ADHD. People carrying those polymorphisms are susceptible to opioid addiction and not necessarily to ADHD.
BACKGROUND: Polymorphisms in genes such as DAT1, 5HTTLPR, D4DR4, and MAO-A have been linked to attention deficit hyperactivity disorder (ADHD) and susceptibility for opiate addiction. We investigated in opiate-addicted parents and their children the rate of ADHD and genetic markers that could predict susceptibility to ADHD and/or opiate addiction. METHODS: We studied 64 heroin-addicted, methadone-maintained parents, and their 94 children who had or had not been exposed prenatally to opiates. DNA extracted from mouthwash was assessed for genetic polymorphism for six polymorphic sites of four different genes. Study subjects also filled a variety of questionnaires assessing the rate of ADHD in the parents and children and the children's intelligence quotient. RESULTS:Children of opiate-dependent mothers had a higher rate of ADHD compared to those of the opiate-dependent fathers. Opiate-dependent parents have a high risk of being carriers of most risk alleles examined except DRD4EX3 (allele 7). There was no difference whether the addicted parents had or did not have ADHD. CONCLUSIONS: Serotonergic and dopaminergic risk alleles seem to be mainly related to opiate dependence with no effect on the occurrence of ADHD. People carrying those polymorphisms are susceptible to opioid addiction and not necessarily to ADHD.
Authors: M Kotler; H Cohen; R Segman; I Gritsenko; L Nemanov; B Lerer; I Kramer; M Zer-Zion; I Kletz; R P Ebstein Journal: Mol Psychiatry Date: 1997-05 Impact factor: 15.992
Authors: Michael M Vanyukov; Brion S Maher; Bernie Devlin; Galina P Kirillova; Levent Kirisci; Ling-Mei Yu; Robert E Ferrell Journal: Psychiatr Genet Date: 2007-12 Impact factor: 2.458
Authors: Jonathan Mill; Naomi Fisher; Sarah Curran; Sandra Richards; Eric Taylor; Philip Asherson Journal: Neuroreport Date: 2003-08-06 Impact factor: 1.837
Authors: Rachel Bachner-Melman; Christian Dina; Ada H Zohar; Naama Constantini; Elad Lerer; Sarah Hoch; Sara Sella; Lubov Nemanov; Inga Gritsenko; Pesach Lichtenberg; Roni Granot; Richard P Ebstein Journal: PLoS Genet Date: 2005-09-30 Impact factor: 5.917
Authors: Su Lynn Yeoh; John Eastwood; Ian M Wright; Rachael Morton; Edward Melhuish; Meredith Ward; Ju Lee Oei Journal: JAMA Netw Open Date: 2019-07-03
Authors: Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang Journal: Front Psychiatry Date: 2019-09-18 Impact factor: 4.157